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Abstract 
 
Background: The in vivo relationship of spinal cord lesion features with 
clinical course and function in MS is poorly defined. 
Objective: To investigate the associations of spinal cord lesion features on 
MRI with MS subgroup and disability. 
Methods: We recruited 120 people: 25 clinically isolated syndrome, 35 
relapsing-remitting (RR), 30 secondary progressive (SP), 30 primary 
progressive (PP) MS. Disability was measured using the expanded disability 
status scale. We performed 3T axial cervical cord MRI, using 3D-fast-field-
echo and phase-sensitive-inversion-recovery sequences. Both focal lesions 
and diffuse abnormalities were recorded. Focal lesions were classified 
according to the number of white matter (WM) columns involved and whether 
they extended to grey matter (GM). 
Results: The proportion of patients with focal lesions involving at least two 
WM columns and extending to GM was higher in SPMS than in RRMS 
(p=0.03) and PPMS (p=0.015). Diffuse abnormalities were more common in 
both PPMS and SPMS, compared with RRMS (OR 6.1 [p=0.002] and 5.7 
[p=0.003] respectively). The number of lesions per patient involving both the 
lateral column and extending to GM was independently associated with 
disability (p<0.001). 
Conclusions: More extensive focal cord lesions, extension of lesions to GM, 
and diffuse abnormalities are associated with progressive MS and disability. 
  
  
Introduction 
Two long disease duration imaging studies in MS have shown that spinal cord 
atrophy is associated with disability, independently from brain atrophy or 
lesion load1, 2. However, neither study investigated the contribution of focal 
spinal cord lesions or diffuse abnormalities3-7 to disease progression. 
Focal spinal cord lesions are typically seen on MRI as hyper-intense 
abnormalities on sagittal T2-weighted images3. However, this approach 
underestimates the number of lesions8 and axial acquisitions improve 
detection9. A further advantage of axial imaging is that involvement of central 
grey matter (GM) and white matter (WM) columns by lesions is more clearly 
determined10-12. 
In a previous pilot study we used a combination of: axial 3D-fast-field-echo 
(FFE) and 3D-phase-sensitive-inversion-recovery (PSIR) scans, on 3T MRI, 
to record the anatomical location of lesions within the cervical cord13. These 
two sequences combined may therefore be useful to investigate spinal cord 
imaging abnormalities (both focal and diffuse) that are associated with 
progression and disability. 
In this present study of a moderately large clinical cohort, we investigate the 
following hypotheses: 
(i) More extensive focal lesions, i.e., involving two or more WM columns, 
occur more frequently in progressive than non-progressive MS. 
(ii) Extension of focal lesions to GM is more common in progressive MS. 
  
(iii) Diffuse abnormalities occur more frequently in progressive MS. 
(iv)  The location of focal cord lesions will affect the association seen with 
disability - with motor disability being particularly related to lateral 
column involvement. 
  
Methods 
Subjects 
We recruited people with CIS, or MS14, subgroups were classified using 
published criteria15. Recruitment was performed without reference to earlier 
spinal cord imaging findings. None of the subjects had a relapse or received 
corticosteroids within a month prior to participation. Disability was recorded 
using the expanded disability status scale (EDSS)16. This study was approved 
by the national research ethics service committee and informed written 
consent was obtained from all participants. 
MRI protocol 
The 3T MRI protocol for this study was as previously described13 (provided in 
full in a supplementary file). Briefly, two 3D-axial sequences were acquired in 
the upper cervical cord centred at C2/C3: FFE and PSIR, with 0.5 x 0.5 mm2 
in plane resolution, as well as a sagittal PD/T2 scan of the cervical cord for 
orientation of the axial slices. In addition a PD/T2 brain scan was acquired for 
identification of brain lesions. 
 
Image analysis 
Using the sagittal image for orientation of axial slices, lesions were first 
recorded on the slice-matched 3D-FFE and 3D-PSIR images by an 
experienced reader (HK) using the classification system described below, with 
subsequent and final confirmation of the presence and classification of all 
lesions being made be a second reader, who was an experienced 
  
neuroradiologist (KM)13. Lesions were analysed on all ten 5mm thick axial 
slices. Both readers were blinded to the clinical status of the cases being 
reviewed. Images degraded by artefacts were excluded from analysis. 
Focal lesions 
We defined focal lesions as abnormal areas of clearly increased signal 
intensity on the 3D-FFE image and decreased signal intensity on 3D-PSIR 
image and a clearly demarcated border from the surrounding tissue. Focal 
lesions were only recorded when they were clearly visible on both scans. 
Focal lesions were always evident in WM, i.e., they had higher signal on 3D-
FFE and lower signal on 3D-PSIR with respect to adjacent WM. While it was 
possible to identify lesions that extended to the GM, it was not possible to 
determine their extent or location within GM as lesion signal intensity was 
generally similar to that of normal cord GM on both sequences.  
Focal lesions were classified based on the number of WM columns involved. 
The column that was maximally covered (in many cases entirely) by a lesion 
was recorded (in comparison to partial coverage of other columns) and if 
extension into one or more additional columns was seen (e.g. a lateral column 
lesion extending into the posterior column) this was also noted. 
The classification system devised for lesions is shown in Table 1. Lesions 
involving a single column were either confined to WM only (type I – 
demonstrated in Figure 1; in these lesions normal appearing cord WM was 
visible between the lesion and GM), or extended to the GM (type II – Figure 
2). When focal lesions involved two (type III –Figure 3) or more (type IV – 
  
Figure 4) columns, they invariably extended to the GM adjacent to the 
affected columns, i.e., no lesions involved two or more columns without 
extending to GM. For lesions that covered multiple slices of the image, their 
extent was classified from the slice with maximal involvement. 
Diffuse abnormalities 
These were defined as abnormal areas of intermediate signal intensity, 
between that of focal lesions and normal appearing spinal cord (Figure 5). 
Diffuse abnormalities also lacked a well demarcated border from adjacent 
normal appearing cord. These were recorded on the 3D-FFE scan, where 
they were visible as an intermediate hyper-intense abnormality relative to the 
normal appearing cord. Diffuse abnormalities were often not seen on the 3D-
PSIR scan, or if they were, they were poorly defined areas of subtle hypo-
intensity relative to normal appearing cord. 
Diffuse abnormalities were recorded, when seen, as present or absent. An 
anatomical classification system based on spinal cord columnar involvement – 
as undertaken for focal lesions - could not be implemented due to the 
absence of a clearly defined border demarcating their termination. 
 
Statistical analysis 
Stata 13 (Stata Corporation, College Station, Texas, USA) was used for 
statistical analysis. Statistics given at lesion level are descriptive only: tests 
were all conducted at subject level. A summary of all the statistical tests 
performed is provided in table format in a supplementary file. 
  
(i) Focal lesion features and diffuse abnormalities: comparison between 
clinical subgroups 
 
To investigate for differences in the number of focal lesions between clinical 
subgroups, we performed a single test for ‘linear trend’17 by regressing the 
lesion variable (i.e. number of lesions) on a group variable coded numerically 
in the order: 0=CIS, 1=relapsing-remitting (RR), 2=primary progressive (PP), 
3=secondary progressive (SP) MS. 
To test whether more extensive (types III and IV) focal lesions, extension to 
GM, and diffuse abnormalities would be seen more frequently in progressive 
MS, we compared these lesion characteristics between groups using logistic 
regression, with the lesional element being compared (lesion extent, 
extension to GM, and diffuse abnormalities) as the binary dependent variable. 
Clinical subgroup indicators were entered as predictors in each model and 
adjustment was made for age, gender and disease duration. Separate 
adjustment was performed so that age and disease duration were not in the 
model simultaneously, since across subject groups disease duration will 
necessarily vary substantially in patients of the same age. Where patients did 
not have a particular lesion characteristic (e.g. diffuse abnormalities) an exact 
chi-square test was used. To minimise the number of comparisons, only the 
following four were performed: RRMS vs. each of the three other groups (CIS, 
PPMS and SPMS), and PPMS vs. SPMS. 
  
Due to the exploratory nature of the study, no adjustment for multiple 
comparisons was performed18.  
(ii) Lesion features: investigation for independent associations with physical 
disability 
A multiple linear regression model was constructed with EDSS as response 
variable on the lesion predictors listed in the supplementary material. A 
standard manual forward stepwise procedure was used as follows: (i) age, 
gender and disease duration were retained in the model throughout; the first 
MRI variable entered was the subject classification according to their most 
extensive lesion; (ii) each MRI variable entered was retained if p<0.05, while 
any MRI variables with p>0.05 were removed; with each new variable 
combination thus constructed, the procedure was repeated, until all MRI 
variables in the model were p<0.05 and no other variable improved the model 
at p<0.05. There was no marked deviation from normality or homoscedascity 
of regression residuals; the regression estimates were confirmed using non-
parametric bias-corrected and accelerated bootstrap19. 
  
Results 
(i) Demographics of clinical subgroups (Table 2) 
We recruited 120 people: 25 CIS, 35 RRMS, 30 SPMS and 30 PPMS. Three 
subjects’ scans were excluded due to motion: CIS (n=1), RRMS (n=1) and 
SPMS (n=1). 
Using the T2-weighted brain scan, criteria for dissemination in space was 
fulfilled in 15 cases of the CIS cohort; it was not possible to investigate for 
dissemination in time, with a single time point non-contrast enhanced scan14. 
(ii) Number of focal spinal cord lesions by type (I-IV) and location (Table 3) 
Lesion numbers in each category (type I-IV) are summarised in Table 3. We 
identified 354 focal spinal cord lesions in total. Although similar numbers of 
type I lesions (involving a single WM column) were seen in all subgroups of 
MS, a higher number of focal lesions that involved two columns (type III) were 
seen in SPMS (n=22) compared to either RRMS (n=16) or CIS (n=2). There 
were also a higher number of type IV lesions (involving three or more WM 
columns) in progressive MS: SPMS (n=8), PPMS (n=5), RRMS (n=1) and CIS 
(n=0). 
Focal lesions involved the lateral and posterior columns (75% and 38% of 
lesions respectively) more frequently than the anterior column (6%). 
Extension to the GM was seen in 67% of the lesions. 
 
(iii) Lesion characteristics by MS subgroup (Table 4) 
  
The proportion of people with one or more focal spinal cord lesions increased 
in the order: CIS (42%), RRMS (85%), PPMS (97%) and SPMS (100%). The 
mean of the total number of lesions per patient similarly increased in the 
order: CIS (mean 0.8), RRMS (2.8), PPMS (3.5) and SPMS (4.7). This 
increase was approximately linear with a significant increase of 1.2 (95% CI 
0.9, 1.6; p<0.001) lesions per MS subgroup. Adjustment for age, gender and 
disease duration did not affect the results. The mean, median and range per 
subject of the number of cord lesions in each subgroup are shown in Table 5. 
The proportion of subjects with more extensive lesions (type III or IV), was 
significantly higher in RRMS vs. CIS (OR 6.8, 95% CI 1.4, 33.9; p=0.019), 
SPMS vs. RRMS (OR 3.1, 95% CI 1.1, 8.7; p=0.033) and in SPMS vs. PPMS 
(OR 3.8, 95% CI 1.3, 11.2; p=0.015). No differences were seen between 
PPMS vs. RRMS (OR 3.2, 95% CI 0.79, 13.3; p=0.104). These significant 
group differences remained after adjusting for age, gender or disease 
duration. 
The proportion of subjects with lesions extending to the GM (type II-IV) was 
also greater in RRMS vs. CIS (OR 8.3, 95% CI 2.5, 27.6; p=0.001) and SPMS 
vs. RRMS (OR 10.1, 95% CI 1.2, 85.3; p=0.034) but not significantly greater 
in SPMS vs. PPMS (OR 3.1, 95% CI 0.3, 31.8; p=0.338). No difference was 
seen between PPMS and RRMS (OR 0.8, 95% CI 0.29, 2.26; p=0.684). 
Diffuse abnormalities were present in over half of PPMS (57%) and SPMS 
(55%) patients but only in 18% of RRMS and none of CIS (p=0.037 for RRMS 
vs. CIS, exact chi-square test). The OR for having diffuse abnormalities was 
higher in PPMS vs. RRMS was 6.1 (CI 2.0, 19.1; p=0.002) and for SPMS vs. 
  
RRMS, 5.7 (95% CI 1.8, 18.1; p=0.003). These significant differences 
remained after adjustment for age, gender or disease duration. 
 
(iv) Independent associations between EDSS and spinal cord lesion 
characteristics 
The best independent predictors of EDSS were found to be the number of a 
subject’s lesions which involved a lateral column and extended to GM 
(p=0.0007), and the subject’s most extensive lesion (i.e. the lesion that 
covered the greatest number of columns in that subject, entered as a single 
term rather than as a categorical variable, p=0.045), in a model also 
containing age at scan (predicted 0.06 increase in mean EDSS per year of 
age, p<0.001), gender (predicted 0.60 higher mean EDSS in men compared 
to women, p=0.032) and disease duration (predicted 0.07 increase in mean 
EDSS per year duration, p=0.001). 
In this model, compared to subjects with no lesions that involved a lateral 
column and extended to GM, having one, two and three or more such lesions 
predicted respectively 0.8 (95% CI -0.26,1.77; p=0.143)), 0.7 (-0.46, 1.81; 
p=0.239) and 2.1 (0.94, 3.32; p=0.001) higher mean EDSS (with p=0.0007 for 
the overall contribution of the categorical variable); and in the same model 
mean EDSS was predicted with borderline significance to be higher by 0.4 
(95% CI 0.01, 0.78; p=0.045) per category of the subject’s most extensive 
lesion. In total 30 patients had three or more lesions that involved a lateral 
column and extended to the GM: RRMS n=6, PPMS n=10; and SPMS n=14. 
  
None of the other MRI variables entered additionally into this model (see 
supplementary Table 2) was significant, but in particular neither (i) the total 
number of lesions, nor (ii) the number of lesions involving a lateral column but 
not extending to GM, nor (iii) the number of lesions extending to GM but not 
involving a lateral column, contributed significantly to the above model, 
confirming the importance of the more specific predictor of lesions that both 
involved a lateral column and extended to GM. 
The proportion of explained variance (R2) was 66%, compared to 46% for a 
model with only age, gender and disease duration, and with 44% for a model 
with just the two lesion variables. 
  
Discussion 
In this study we demonstrate two new associations of spinal cord lesion 
characteristics with clinical status and disability in MS. Firstly, focal lesions 
involving at least two spinal cord WM columns and extending to the GM (Type 
II and IV lesions) are more frequent in SPMS. Secondly, focal lesions that 
involve lateral columns and extend to GM are independently associated with 
disability. We also confirmed previous observations in finding a significant 
association between diffuse abnormalities and progressive MS4-7.  
Post mortem spinal cord studies have demonstrated extensive focal lesions 
involving several WM columns and GM20, 21. However, due to inherent 
limitations of spinal cord imaging22, there has been little information on the 
anatomical location of focal lesions seen on axial in vivo images in 
progressive MS, and how those features compare with findings in the earlier 
relapsing remitting phase of the disease. 
Although some previous imaging studies demonstrated a greater number of 
focal lesions in SP than RRMS4, 5, 9, 23, our study extends these findings. 
Firstly, this was the first study to document a greater number of spinal cord 
columns covered by individual focal lesions in SPMS. This observation was in 
comparison to RRMS and CIS, where focal lesions, were more often 
restricted to a single column. 
Secondly we invariably detected extension to the GM when focal lesions were 
themselves more extensive (i.e. they involved at least two WM columns). 
Although we could not directly determine the how much of the GM was 
  
affected by the lesions, our findings are consistent with spinal cord GM 
involvement being extensive in SPMS, and are in line with pathology reports, 
where 56% and 67% of focal lesions involved the GM 24, 25. 
Although the total number of lesions detected was greater in PPMS than 
RRMS, neither the number of lesions involving two or more WM columns, nor 
extension to the GM, differed significantly from RRMS. These results are in 
agreement with previous studies demonstrating similar focal spinal cord lesion 
abnormalities in both RRMS and PPMS3, 5, 23. 
The mechanisms that account for the greater number of lesions covering two 
or more WM columns in SPMS cannot be determined from this current study. 
However, this subgroup had disease duration of two decades, which may 
result in a more prolonged exposure to pathogenic processes that underlie the 
formation of new focal lesions, accounting in turn for the greater number of 
extensive lesions seen. 
A question arising from this observation is whether lesions restricted to a 
single column of the cord evolve to encompass multiple columns. Extensive 
inflammation and demyelination26 seen pathologically, may provide a milieu 
conducive to the formation of new extensive lesions and/or coalescence of 
existing lesions. Longitudinal studies are required to elucidate the processes 
involved. 
Diffuse abnormalities may be seen on sagittal PD-weighted images in MS and 
are more commonly seen in PPMS4-8. In this present study, people with 
progressive MS were almost six times more likely to have diffuse 
  
abnormalities, compared to RRMS. Diffuse abnormalities may reflect 
demyelination and/or axonal loss as reported at post mortem5, 8. 
This current study demonstrates an independent association of disability with 
focal lesions that involve both the lateral column and extend to GM, which 
may reflect damage in the corticospinal tract, and/or GM inter-neuronal loss27. 
Recent studies have shown that both atrophy and microstructural 
abnormalities in cord GM are associated with disease progression in MS28, 29. 
The sequences used in our study could not differentiate lesional from non-
lesional cord GM and future studies are needed to identify image contrast 
modalities that enable depiction and quantitation of lesions within cord GM. 
The independent association of the most extensive focal lesions with disability 
was only of borderline significance. This probably reflect several factors 
including limited pathological specificity of the imaging sequences employed, 
variable functional effects according to lesion location within the cord, and 
effects of remote lesions outside of the cord region studied. In a recent report 
of a cohort with long disease duration MS, several MRI measures including 
lesions in the cervical cord and infratentorial regions were associated with 
disability30. 
A number of limitations should be considered in the interpretation of the 
results of this study. Firstly, the images were restricted to the upper cervical 
cord. This approach minimised physiological motion and likely provided the 
greatest yield of lesions20, 21. A future study would be of interest that employs 
axial sequences with greater coverage9, measures of cord atrophy30 and 
quantitative MRI31. Although an association of cord atrophy and disability is 
  
well recognised, the sequences we used to detect lesions were not suited to 
investigate atrophy of the whole cord or grey or white matter. Secondly, the 
extent of lesions within the cord GM could not be quantified24, nor was it 
possible to visualise subpial lesions20, 21, therefore neither of these features 
could be incorporated into the classification system used. This may be 
improved in future studies using higher image resolution, modified spinal cord 
coil designs, and higher field strength imaging32. Finally this cross-sectional 
study did not facilitate investigation of the progression of abnormalities, which 
could be addressed longitudinally. 
 
Through the use of high resolution axial cervical cord MRI, we have 
demonstrated significant associations of progressive MS and disability with 
focal cord lesion location and extent and with diffuse abnormalities. Future 
longitudinal studies are warranted to investigate the potential of cord lesion 
imaging to help understand and monitor MS disease progression. 
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Type I Spinal cord lesion involving a single 
column and confined to the white 
matter 
Type II Spinal cord lesion involving a single 
column and grey matter 
Type III Spinal cord lesion involving two 
columns and grey matter 
Type IV Spinal cord lesion involving three or 
four spinal cord columns and grey 
matter 
 
Table 1. Classification system used for focal spinal cord lesions identified on 
axial scans 
  
 
 CIS* 
n = 25 
RRMS 
n = 35 
PPMS 
n = 30 
SPMS 
n = 30 
Age (years) 36.5 ± 9.0 38.7 ± 9.7 50.6 ± 
9.9 
51.1 ± 9.2 
Gender 
Female:Male 
14:11 23:12 13:17 18:12 
Disease 
duration 
(years) 
0.4 ± 0.4 6.5 ± 5.2 10.4 ± 
7.5 
19.9 ± 11.5 
Median 
EDSS 
(range) 
1 (0 – 3.5) 2.5 (0 – 6) 6 (2 – 
7.5) 
6.5 (4 - 8) 
Disease 
modifying 
drugs (%) 
0 (0) 19† (54) 0 (0) 5‡ (17) 
 
Table 2. Demographics of all people with a clinically isolated syndrome or MS 
recruited for this study. Data represents mean ± standard deviation. The CIS 
cohort*: optic neuritis (n=21), partial myelitis (n=2), multifocal CIS (n=1; optic 
neuritis with a brainstem syndrome) and hemispheric presentation (n=1; 
unilateral hand weakness due to a motor cortex lesion). †Disease modifying 
drugs in RRMS cohort: -interferon (n=13), natalizumab (n=5), and glatiramer 
acetate (n=1). ‡SPMS cohort: -interferon (n=5). 
 
 
  
 
Total number 
of lesions 
Type I Type II Type III Type IV Grey matter 
involvement 
Anterior 
column 
Posterior 
column 
Lateral 
column 
CIS  
n = 18 
8 (44.5%) 8 (44.5%) 2 (11%) 0 (0%) 10 (56%) 2 (11%) 5 (28%) 13 (72%) 
RRMS  
n = 94 
36 (38%) 41 (44%) 16 (17%) 1 (1%) 58 (62%) 5 (5%) 38 (40%) 67 (71%) 
PPMS  
n = 106 
36 (34%) 55 (52%) 10 (9%) 5 (5%) 70 (66%) 7 (7%) 37 (35%) 79 (75%) 
SPMS  
n = 136 
37 (27%) 69 (51%) 22 (16%) 8 (6%) 99 (73%) 6 (4%) 54 (40%) 107 (79%) 
All subjects 
n = 354 
117 (33%) 173 (49%) 50 (14%) 14 (4%) 237 (67%) 20 (6%) 134 (38%) 266 (75%) 
 
Table 3. The number (percentage) of focal lesion types (I-IV) and also the number of focal lesions involving the spinal cord grey 
matter and each column of the spinal cord in each clinical subgroup. Note: the cumulative numbers of lesions with specified white 
matter column involvement exceeds the total number of lesions, since some lesions seen involved more than one column e.g. 
extension into the lateral and posterior column by the same lesion.  
  
Total number 
of people 
Number of 
people with 
focal spinal 
cord lesions 
Number of 
people with 
Type I lesions 
Number of 
people with 
Type II 
lesions 
Number of 
people with 
Type III 
lesions 
Number of 
people with 
Type IV 
lesions 
Number of 
people with 
lesions 
involving the 
grey matter 
Number of 
people with 
diffuse 
abnormalities 
CIS 
n = 24 
10 (42%) 8 (33%) 5 (21%) 2 (8%) 0 (0%) 6 (25%) 0 (0%) 
RRMS 
n = 34 
29 (85%) 20 (59%) 21 (62%) 12 (35%) 1 (3%) 25 (74%) 6 (18%) 
PPMS 
n = 30 
29 (97%) 22 (73%) 25 (83%) 9 (30%) 5 (17%) 27 (90%) 17 (57%) 
SPMS 
n = 29 
29 (100%) 20 (69%) 27 (93%) 17 (59%) 7 (24%) 28 (97%) 16 (55%) 
 
Table 4. Number (percentage) of people with clinically isolated syndrome or multiple sclerosis with focal spinal cord lesions (of any 
type; types 1-4 individually; involving grey matter) and with diffuse abnormalities. Note: Three peoples’ scans were excluded from 
analysis due to motion artefacts on images: clinically isolated syndrome (n = 1), relapsing remitting MS (n = 1) and secondary 
progressive MS (n = 1). 
 
 
  
 
Number 
of people 
Type I Type II Type III Type IV All focal 
lesions 
Grey matter 
involvement 
CIS 
n = 24 
0.33, 0 
(0-1) 
0.33, 0 
(0-2) 
0.08, 0 
(0-1) 
0, 0 (0) 0.8, 0 (0 - 
4) 
0.42, 0 (0-
3) 
RRMS 
n = 34 
1.06, 1 
(0-5) 
1.21, 1 
(0-4) 
0.47, 0 
(0-3) 
0.03, 0 
(0-1) 
2.8, 2.5 (0 
-8) 
1.71, 1 (0-
5) 
PPMS 
n = 30 
1.20, 1 
(0-4) 
1.83, 1.5 
(0-6) 
0.33, 0 
(0-2) 
0.17, 0 
(0-1) 
3.5, 3 (0 - 
7) 
2.33, 2 (0-
6) 
SPMS 
n = 29 
1.27, 1 
(0-5) 
2.37, 2 
(0-6) 
0.75, 1 
(0-3) 
0.28, 0 
(0-2) 
4.7, 4 (2 - 
9) 
3.41, 3 (0-
8) 
 
Table 5. Mean, median (range) per subject of the number of spinal cord lesions in 
each category and involving the grey matter in each of the four clinical subgroups. 
  
 
Figure 1. Three cases of lesions involving a single spinal cord column restricted to 
the white matter (Type I lesions). 1A-C: 3D-fast field echo 0.5 x 0.5 mm2 in plane 
resolution, 1D-F: 3D-phase sensitive inversion recovery 0.5 x 0.5 mm2 in plane 
resolution. Focal lesions are marked by a single yellow chevron and are located in 
the right lateral column (Figures A/D and C/F) and in the left lateral column (Figures 
B/E and C/F). Figure A/D: 36 year old female with RRMS, EDSS 2. Figure B/E: 42 
year old male with RRMS, EDSS 2.5. Figure C/F: 60 year old male with PPMS, 
EDSS 4. 
  
 
Figure 2. Three cases of focal lesions involving a single spinal cord column also 
extending to the grey matter (Type II lesions). 2A-C: 3D-fast field echo 0.5 x 0.5 mm2 
in plane resolution, 2D-F: 3D-phase sensitive inversion recovery 0.5 x 0.5 mm2 in 
plane resolution. These focal lesions are demonstrated in the left lateral column by a 
single chevron in A/D and C/F. A focal lesion involving the posterior column is 
demonstrated in Figures B/E. A separate focal lesion restricted to the white matter 
(Type I lesion) is demonstrated in the left lateral column (Figure B and E) indicated 
by a single arrowhead. Diffuse abnormalities are demonstrated on the 3D-fast field 
echo images 2B and 2C in the right lateral column indicated by a double chevron. 
Figure A/D: 36 year old female with RRMS, EDSS 2. Figure B/E: 42 year old male 
with RRMS, EDSS 2.5. Figure C/F: 35 year old female with RRMS, EDSS 1. 
  
 
Figure 3. Three cases of focal lesions (indicated by single chevrons) involving two 
spinal cord columns and extending to the grey matter (Type III lesions). 3A-C: 3D-
fast field echo 0.5 x 0.5 mm2 in plane resolution, 3D-F: 3D-phase sensitive inversion 
recovery 0.5 x 0.5 mm2 in plane resolution. A focal lesion involving the anterior and 
posterior columns and extending to grey matter is demonstrated in Figures A and D. 
Figure A also shows diffuse abnormalities in the right lateral column (indicated by 
double chevron). Figure B and E demonstrate a lesion involving the right lateral and 
posterior column and extending to grey matter (type III) and also a separate focal 
lesion in the left lateral column only (type I) indicated by a single arrowhead. A focal 
lesion involving the right lateral and anterior column and extending to grey matter is 
demonstrated in Figure C and F. Figure A/D: 53 year old male with PPMS, EDSS 
7.5. Figure B/E: 55 year old female with SPMS, EDSS 6. Figure C/F: 24 year old 
female with RRMS, EDSS 0. 
  
 
Figure 4. Three cases of lesions involving three spinal cord columns and extending 
to the grey matter (Type IV lesions). 4A-C: 3D-fsat field echo 0.5 x 0.5 mm2 in plane 
resolution, 4D-F: 3D-phase sensitive inversion recovery 0.5 x 0.5 mm2 in plane 
resolution. Focal lesions are labelled in all images by a single chevron. Figure A/D: 
45 year old male with PPMS, EDSS 6.5. Figure B/E: 55 year old female with SPMS, 
EDSS 6. Figure C/F: 24 year old male with RRMS, EDSS 3. 
  
 
Figure 5: Images demonstrating diffuse abnormalities on 3D-fast field echo images 
(A and B) shown by double chevrons. Corresponding slices of 3D-phase sensitive 
inversion recovery images are shown in images C and D. Figures A/C: 55 year old 
male with PPMS, EDSS 5. Figures B/D: 49 year old female with PPMS, EDSS 7.5. 
 
 
 
